Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform ™ drug optimization technology, announced that Randall ...

Measles is making a troubling comeback in the U.S., driven by declining vaccination rates and rising vaccine hesitancy.